3Strader DB, Wright T, Thomas DL, et al. Diagnosis, management, andtreatmentof hepatitis C [ J ]. Hepatology, 2004, 39 : 1147 - 1171. 被引量：1
4Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量：1931
8Anna Liberek,Anna Szaflarska-Poplawska,Maria Korzon,Gra(?)yna (?)uczak,Magdalena Góra-Gebka,Ewa (?)o(s|')-Rycharska,Wanda Bako,Mieczyslawa Czerwionka-Szaflarska.Lamivudine therapy for children with chronic hepatitis B[J].World Journal of Gastroenterology,2006,12(15):2412-2416. 被引量：4
9Honkoop P, De Man RA. Entecavir: a potent new antiviral drug for hepatitis B. Expert Opin Investig Drugs, 2003, 12: 683-688. 被引量：1
10Seifer M, Hamatake RK, Colonno RJ, et al. In vitro inhibition of hepadnavirus polymerases by the triphosphates of BMS-200475and lobucavir. Antimicrob Agents Chemother, 1998, 42: 3200-3208. 被引量：1
